Covered recipient · General Payments record
ABDULAZIZ JOURY
General Payments · PY2019–2022
$3,271.43
- Reported across 84 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $251.38 | 8 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Esperion Therapeutics, Inc. | $124.49 | 1 |
| Amgen Inc. | $47.86 | 2 |
| PFIZER INC. | $30.64 | 2 |
| Acerta Pharma LLC | $26.60 | 2 |
| E.R. Squibb & Sons, L.L.C. | $21.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (8)
Sorted by paying entity, then date · as published by CMS
Program year 2022 201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $29.09 | 03/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 946542215 | CMS |
| Amgen Inc. | $18.77 | 05/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 946542211 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.60 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920259531 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.00 | 05/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920260007 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.79 | 05/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 932962813 | CMS |
| Esperion Therapeutics, Inc. | $124.49 | 03/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 947263015 | CMS |
| PFIZER INC. | $14.73 | 01/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949296241 | CMS |
| PFIZER INC. | $15.91 | 03/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949487371 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.